Skip to main content

5 December 2023

Last updated: Monday 4 December 2023

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Developing biosimilar monoclonal antibodies will not be easy

Wednesday 23 March 2011

Interviewee/Contributor

Gabriele Schaffner-Dallmann

Organisation

Pharmatching GmbH

Organisations

Biotec Pharmacon ASA
Edison Investment Research
London Stock Exchange
EMEA
Medical Marketing International Group plc
Kiadis Pharma BV
Eli Lilly and Company
Vivoryon Therapeutics AG
Novo Seeds
Forbion

Interviewees and Contributers

Bruce Booth
John Lisman
Chantal van Gils
Tara Raveendran
Michael Valenzuela
Elizabeth Foot
Stephen Poole
Keith Thompson
Vincent Mutel
Catherine Taylor

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Eva-Lotta Allan is chair at Maxion Therapeutics

Thursday 2 November 2023

Myricx appoints head of clinical development

Wednesday 1 November 2023

Mikaela Bruhammar is COO at BC Platforms

Wednesday 1 November 2023

Jazz Pharmaceuticals appoints CFO

Wednesday 1 November 2023

iOmx Therapeutics has new CBO

Wednesday 1 November 2023

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2023 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form